Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA4 | P22748 | 4/20 | 0.43 |
| ▸ | CA9 | Q16790 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | TTPA | P49638 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15503343 | 0.89 | NPSR1 (0.38) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL27819169 | 0.82 | POLB (0.46) | POLBGAANPSR1ALDH1A1PRKCA | |
| SCHEMBL29049106 | 0.80 | POLB (0.44) | POLBGAANPSR1ALDH1A1PRKCA | |
| SCHEMBL2547168 | 0.79 | PTGS2 (0.54) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL16914691 | 0.78 | CA12 (0.49) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL7989588 | 0.77 | POLB (0.46) | POLBGAANPSR1ALDH1A1PRKCA | |
| SCHEMBL3651730 | 0.77 | PTGS2 (0.52) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL3649974 | 0.77 | PTGS2 (0.52) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL3649023 | 0.77 | PTGS2 (0.52) | PTGS2CA12CA1CA2CA4 | |
| SCHEMBL10157919 | 0.76 | PTGS2 (0.34) | PTGS2CA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | NORTHEASTERN UNIVERSITY | 2021-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | CNR2, CNR1, GPR18 | PTGS2 629/4885CA12 2982/4885CA1 3001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.